Top compounds associated with response to MTFR2


Feature Type Standardized
Nominal ANOVA
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.086 0.03
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.03
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.03
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.083 0.03
mRNA Merck60 CTRPv2 pan-cancer AAC 0.07 0.03
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.075 0.03
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA GW-405833 CTRPv2 pan-cancer AAC 0.078 0.04
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.11 0.04
Download CSV